Current Setup & Catalysts

Current Setup & Catalysts — Partners Group Holding AG (PGHN)

Figures converted from Swiss francs (CHF) at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, multiples, percentages, AuM (reported by the firm in USD) and dates are unitless or already in USD and are unchanged.

The one-line read. Partners Group trades at $813 — down roughly a third year-to-date, pinned within 3% of its 52-week low and deeply oversold (RSI ~24) — not because earnings broke, but because in June 2026 it gated its USD 8.6bn Global Value evergreen fund and the market began pricing a structural break in the perpetual-capital growth engine. The next two events — a mid-July H1 AuM update and the 1 September 2026 H1 results — are the first hard reads on whether that fear is real, and they sit on top of an unresolved, genuinely binary mark-integrity allegation. This page is the bridge from the durable 5-to-10-year thesis (a locked-capital fee annuity) to the near-term evidence path that updates it; it is not a verdict (see Bull and Bear for that).

All financial figures are in US dollars, converted from the firm's CHF reporting currency at historical rates. AuM and fund sizes are reported by the firm in USD. A native CHF version of this page is available.

Source: price, YTD and momentum from the staged daily price/technical feed, as reported; forward P/E on FY2026 consensus EPS of $57.5 and dividend yield on the $56.9 proposed dividend [5].

Source: next-earnings date 1 September 2026 per the staged earnings calendar; H1 AuM-update window per the firm's established July cadence (the firm published a mid-year AuM update in July 2025).

Where we are right now

The setup is mixed and unusually tense: a verifiably high-quality franchise trading on a distressed tape. The fundamentals that anchor the long-term thesis are intact — FY2025 was a record (performance fees up 60% to $1,033m, 32% of revenue) [3], the management-fee rate held at 1.24% inside its two-decade 1.18–1.33% band [4], and the board lifted the dividend 10% to $56.9 at a 95% payout [5]. Yet the stock has de-rated from ~20x to ~14x in six months on two shocks: a 19 May short report (Grizzly) alleging up to ~40% of evergreen marks may be inflated, and the 3 June gating of the Global Value SICAV at 5% of NAV per quarter after Q2 redemption requests reached ~9.8% of NAV — which produced a -16.3% day, the worst since the 2006 IPO. Management has since quantified the actual damage as a 1–2% drag on net AuM growth in H2 2026/2027 and reconfirmed USD 26–32bn of gross new client demand [1].

The narrative arc is sharp. Six months ago the market debated how fast AuM would compound toward the firm's base case of above USD 450bn by 2033 [7]. Today it debates whether the perpetual-capital channel that carries that doubling is durable at all — and whether the NAVs that anchor both the fee base and 32% of revenue are honest. Those two worries are correlated: a spreading redemption wave would force markdowns, which would simultaneously cut the fee base, validate the short, and pressure the 95%-covered dividend. That correlated tail is what the de-rating prices.

The variant view, sized

We are not consensus-aligned on the risk distribution, and that is where the edge sits. The Street still carries a Buy with a mean target of $1,195 (range 941–1,485) and FY2026 EPS of $57.5 — yet the tape (14x, ~7% yield, -36% YTD, RSI ~24) is pricing a structural-break tail far worse than management's own 1–2% AuM drag [1]. Our variant, in numbers:

• On the durable line, we sit at or above consensus. Management guides evergreen fundraising to exceed outflows in H1 2026, gross demand of USD 26–32bn against tail-downs of only USD -10 to -13bn [2]. If that holds, the recurring 68% of revenue keeps compounding and the ~$27.6 H1 EPS estimate is reachable. The fee rate has never broken its band through a tenfold AuM scaling [4].
• The real swing is performance fees, and here we lean cautious vs. the optical EPS. 2026 carry is guided to the lower part of the 25–40% range because 2025 pulled exits forward [2]. Strip carry toward ~25% of revenue and normalized EPS is closer to $51–52 (the bear's number, ~-10% vs. the $57.5 consensus); a clean exit normalization supports ~$62 (the bull's). So the EPS distribution around the print is roughly -10% to +8%, but the multiple — 11x bear to 18x bull on today's price — is the far bigger lever.
• Net: the market prices the marks/flight tail; we think the flow data and management's 1–2% drag do not support that tail, making the near-term setup modestly asymmetric to the upside into a washed-out tape — but the mark-integrity allegation is a genuine, unhandicappable binary that caps conviction and is the one thing we cannot variant-model. Buy the de-rating with a clean H1 flow print as the cheap insurance.

How this stock actually moves — the price-reaction base rate

Magnitude claims below are anchored here, not to a High/Medium/Low vibe. Over the last six months — the regime that matters — PGHN's scheduled operating prints moved the stock ±3–5%, while flow/mark surprises drove 4–16% single-day moves. The average absolute one-day reaction across these five events was ~6.4%; the gate alone was a -16.3% day on 7.3x normal volume. The read-through: with the stock now positioned for a tail and oversold, the July/September flow events are ±8–15% events, not routine ±3% prints.

Source: daily price and unusual-volume series (staged feed), as reported; event labels per company disclosures and the corpus news digest. Scheduled prints moved ±3–5%; the flow/mark shocks of June drove the tail.

The live debate — what the market is watching now

Sources: revenue mix and performance-fee share [3]; Level-3 valuation judgment [11]; base-case AuM to 2033 [7].

The ranked catalyst timeline

Ranked by decision value to an institutional holder, not by date. The two flow events dominate because they directly resolve the thesis's fault line; the mark-integrity binary ranks high on stakes despite a soft date. Magnitude figures for High-impact rows are anchored to the ±8–15% base rate above and the EPS/multiple spread in the variant view.

Sources for dated commitments and windows: FY2026 outlook (USD 26-32bn gross demand, USD -10 to -13bn tail-downs, performance income 25-40% lower-part-of-range) [2]; the gate, ~9.8% Q2 redemptions, 1-2% AuM drag and the 12 June "no plans to freeze" statement [1]; performance-fee Write-Down Test / reversal constraint [12]; PwC key audit matters [13]; $619m (CHF 500m) 0.40% bond maturing 21 June 2027 [10]; next-earnings date 1 September 2026 per the staged earnings calendar; the July AuM-update window per the firm's July cadence.

Resolution vs. information — which catalysts actually close the debate

Not every event updates the durable thesis. The table separates those that resolve an underwriting variable from those that merely inform.

Sources: available liquidity $4.7bn (CHF 3,721m) and covenant-free facility [9]; valuation/revenue key audit matters [13].

The next 90 days

The calendar is, unusually for this name, dense and decision-rich — both near-term events test the thesis's fault line directly:

• ~15 July 2026 — H1 AuM update (soft date). What matters more than the headline AuM number is the evergreen net flow line and whether any vehicle beyond the Global Value SICAV has hit its cap. A net-positive evergreen read, consistent with management's "fundraising exceeds outflows in H1" guidance [2], is the cheapest available disconfirmation of the bear's primary trigger. This is the first dated test of the whole de-rating.
• 1 September 2026 — H1 2026 results (confirmed). Watch, in order: (1) any performance-fee reversal — the single cleanest tell on mark integrity, given the firm's own reversal constraint [12]; (2) evergreen/private-wealth net flows and gate status; (3) cash conversion of accrued fees; (4) the management-fee margin. The recurring line, not the headline EPS, is the thesis.
• Continuous (through Q3) — the next quarterly redemption window (~end-September), the firm's promised Grizzly rebuttal/legal follow-through, and peer gating read-throughs (Blackstone BCRED and the BDC complex) that move the sector risk premium.

There is no thin-calendar problem here; if anything, the risk is over-reacting to a single July data point before the fuller September print.

What would change the view

Three observable signals over the next ~6 months would most change the underwriting debate — this is the event path, not Stan's verdict:

1. Evergreen net flows across multiple vehicles (July update / September H1). Persistent net outflows or a second gate beyond the Global Value SICAV would attack the "locked capital" premise that underwrites both the fee annuity and the doubling-to-2033 growth case [7] — the thesis's #1 fault line. Conversely, net inflows holding inside the USD 26–32bn guide bleeds the bear out [2].
2. A performance-fee reversal or a break in cash conversion of accrued fees at H1 — the concrete, in-the-numbers tell that the mark-integrity allegation has substance. Its absence (a repeat of ~119% conversion) is the strongest available rebuttal short of the audit.
3. A regulator/auditor action on the Grizzly allegations, or — at the other tail — a clean FY2026 audit re-affirming the valuation and revenue-recognition KAMs unqualified [13]. This is the binary the market cannot yet handicap.

A secondary, slow-moving watch is succession governance — co-founder Wietlisbach's PG3 carve-out (~16 June 2026) and rising related-party dealings — which caps the re-rating but does not break the thesis in this window.